Zacks Investment Research upgraded shares of Relx N.V. (NYSE:RENX) from a hold rating to a buy rating in a report published on Saturday morning. Zacks Investment Research currently has $24.00 target price on the technology company’s stock.
According to Zacks, “RELX NV provides professional information solutions primarily in North America and Europe. The company’s operating segments consists of Scientific, Technical & Medical; Risk & Business Information; Legal, and Exhibitions. Scientific, Technical & Medical segment provides information and tools to help customers improve scientific and healthcare outcomes. Risk & Business Information segment provides data and analytics which enable customers to evaluate and manage risk. Legal segment provides legal, regulatory, news, business information and analysis to legal, corporate, Government and academic customers. Exhibitions segment, through the subsidiary Reed Exhibitions, organizes market events relevant to industry needs. RELX NV, formerly known as Reed Elsevier NV, is based in Amsterdam, the Netherlands. “
Separately, BidaskClub raised shares of Relx N.V. from a hold rating to a buy rating in a report on Saturday, August 19th.
Relx N.V. (NYSE RENX) opened at 21.59 on Friday. The company has a market capitalization of $43.51 billion, a P/E ratio of 26.65 and a beta of 0.86. Relx N.V. has a one year low of $14.92 and a one year high of $21.65. The firm has a 50-day moving average of $20.95 and a 200 day moving average of $19.89.
The company also recently declared a None dividend, which was paid on Wednesday, August 30th. Shareholders of record on Friday, August 4th were given a $0.131 dividend. The ex-dividend date was Wednesday, August 2nd.
Several institutional investors and hedge funds have recently bought and sold shares of RENX. JPMorgan Chase & Co. boosted its position in shares of Relx N.V. by 1,953.0% in the first quarter. JPMorgan Chase & Co. now owns 174,445 shares of the technology company’s stock worth $3,237,000 after purchasing an additional 165,948 shares during the period. Parametric Portfolio Associates LLC boosted its position in shares of Relx N.V. by 15.0% in the second quarter. Parametric Portfolio Associates LLC now owns 810,884 shares of the technology company’s stock worth $16,769,000 after purchasing an additional 105,521 shares during the period. Morgan Stanley boosted its position in shares of Relx N.V. by 83.9% in the first quarter. Morgan Stanley now owns 176,616 shares of the technology company’s stock worth $3,278,000 after purchasing an additional 80,567 shares during the period. Karp Capital Management Corp bought a new position in shares of Relx N.V. in the first quarter worth approximately $1,228,000. Finally, Bank of America Corp DE boosted its position in shares of Relx N.V. by 6.6% in the first quarter. Bank of America Corp DE now owns 1,040,732 shares of the technology company’s stock worth $19,316,000 after purchasing an additional 64,722 shares during the period. Institutional investors and hedge funds own 1.07% of the company’s stock.
About Relx N.V.
RELX NV is a holding company, which holds interests in RELX Group plc. RELX Group is a global provider of information and analytics for professional and business customers across industries. The Company operates in four segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal, and Exhibitions.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Relx N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx N.V. and related companies with MarketBeat.com's FREE daily email newsletter.